Peroxisome proliferator-activated receptor-α ligands inhibit cardiac lipoprotein lipase activity

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 281, Issue 2 50-2, 2001, Pages

  Carroll, Rogayah ^a   Severson, David L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

BM 17.0744; Fatty acids; Lipoprotein metabolism; Wy 14643

Indexed keywords

2,2 DICHLORO 12 (4 CHLOROPHENYL)DODECANOIC ACID; DEXAMETHASONE; HEPARIN; INSULIN; LIGAND; LINOLEIC ACID; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIRINIXIC ACID; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034890019     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.281.2.h888     Document Type: Article

References (36)

1. Fatty acids reduce heparin-releasable LPL activity in cultured cardiomyocytes from rat heart
2. PPARγ, the ultimate thrifty gene
3. Forms of lipoprotein lipase in rat tissues: In adipose tissue the proportion of inactive lipase increases on fasting
4. Peroxisome proliferator-activated receptors in the cardiovascular system
5. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-α, -β, and -γ in the adult rat
6. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor α
7. Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes
8. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin
9. Regulation of the synthesis, processing and translocation of lipoprotein lipase
10. Post-transcriptional mechanisms are responsible for the reduction in lipoprotein lipase activity in cardiomyocytes from diabetic rat hearts
11. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice
12. Lipoprotein lipase activity in rat cardiomyocytes is stimulated by insulin and dexamethasone
13. Lipoprotein lipase activity is stimulated by insulin and dexamethasone in cardiomyocytes from diabetic rats
14. Insulin and dexamethasone stimulation of cardiac lipoprotein lipase activity involves the actin-based cytoskeleton
15. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
16. Peroxisome proliferator-activated receptor-α activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis
17. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
18. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
19. Orphan nuclear receptors: Shifting endocrinology into reverse
20. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
21. Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates
22. Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice
23. Glycolysis is predominant source of myocardial ATP production immediately after birth
24. PPARγ: An essential regulator of adipogenesis and modulator of fat cell function
25. Species differences in induction of hepatic enzymes by BM 17.0744, an activator of peroxisome proliferator-activated receptor α (PPARα)
26. 17-FBM.0744: A structurally new antidiabetic compound with insulin-sensitizing and lipid-lowering activity
27. Thiazolidinediones inhibit lipoprotein lipase activity in adipocytes
28. Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rat hearts by plasma lipids
29. PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
30. Refinement of the Coomassie blue method of protein quantification
31. Peroxisome proliferator-activated receptor α in metabolic disease, inflammation, atherosclerosis and aging
32. Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes
33. Effects of fatty acids on uncoupling protein-2 expression in the rat heart
34. Fatty acid homeostasis in the normoxic and ischemic heart
35. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
36. Lipotoxic heart disease in obese rats: Implications for human obesity